Stocks Overview

LAST PRICE
6.3000
TODAY'S CHANGE (%)
Trending Down-0.1800 (-2.7778%)

Bid / Lots
6.2200/ 2
Ask / Lots
6.3300/ 10
Open / Previous Close
6.6900 / 6.4800
Day Range
Low 6.2150
High 6.7600
52 Week Range
Low 4.0300
High 8.6600
Volume
2,446,286
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 6.48
Time	Volume	BCRX
09:32 ET	69566	6.72
09:34 ET	7215	6.67
09:36 ET	6068	6.63
09:38 ET	8698	6.59
09:39 ET	8005	6.6
09:41 ET	3914	6.5575
09:43 ET	3854	6.585
09:45 ET	16281	6.57
09:48 ET	12194	6.545
09:50 ET	4214	6.56
09:52 ET	4356	6.505
09:54 ET	9340	6.52
09:56 ET	5212	6.54
09:57 ET	4874	6.535
09:59 ET	7068	6.5297
10:01 ET	3585	6.5336
10:03 ET	3578	6.51
10:06 ET	7953	6.51
10:08 ET	3701	6.495
10:10 ET	4319	6.49
10:12 ET	3926	6.47
10:14 ET	3995	6.49
10:15 ET	3455	6.495
10:17 ET	4671	6.52
10:19 ET	5665	6.55
10:21 ET	5211	6.515
10:24 ET	34420	6.52
10:26 ET	1820	6.505
10:28 ET	7084	6.5311
10:30 ET	1661	6.51
10:32 ET	26700	6.49
10:33 ET	4591	6.49
10:35 ET	3100	6.485
10:37 ET	4155	6.485
10:39 ET	2872	6.49
10:42 ET	2350	6.465
10:44 ET	9500	6.45
10:46 ET	34859	6.4969
10:48 ET	3270	6.48
10:50 ET	7133	6.475
10:51 ET	8645	6.505
10:53 ET	2052	6.5
10:55 ET	3976	6.51
10:57 ET	4309	6.505
11:00 ET	500	6.5
11:02 ET	2588	6.505
11:04 ET	1593	6.515
11:06 ET	4146	6.49
11:08 ET	3632	6.495
11:09 ET	900	6.5
11:11 ET	2052	6.495
11:13 ET	2422	6.485
11:15 ET	1983	6.49
11:18 ET	3939	6.495
11:20 ET	2426	6.5
11:22 ET	2393	6.505
11:24 ET	1382	6.51
11:26 ET	303	6.51
11:27 ET	2041	6.5232
11:29 ET	2400	6.52
11:31 ET	2944	6.525
11:33 ET	2805	6.53
11:36 ET	1700	6.53
11:38 ET	600	6.54
11:40 ET	3860	6.545
11:42 ET	800	6.54
11:44 ET	1636	6.545
11:45 ET	100	6.54
11:49 ET	4913	6.54
11:51 ET	500	6.54
11:54 ET	10150	6.53
11:56 ET	2114	6.525
11:58 ET	3111	6.5301
12:00 ET	11844	6.535
12:02 ET	550	6.535
12:03 ET	975	6.55
12:05 ET	300	6.55
12:07 ET	6875	6.54
12:09 ET	3318	6.53
12:12 ET	1010	6.525
12:14 ET	2129	6.52
12:16 ET	3340	6.485
12:18 ET	1053	6.4788
12:20 ET	5705	6.49
12:21 ET	4429	6.46
12:23 ET	2488	6.465
12:25 ET	2072	6.47
12:27 ET	1300	6.465
12:30 ET	1568	6.46
12:32 ET	4606	6.465
12:34 ET	708	6.46
12:36 ET	2291	6.47
12:38 ET	3161	6.47
12:39 ET	8740	6.45
12:41 ET	7570	6.45
12:43 ET	29172	6.47
12:45 ET	5422	6.47
12:48 ET	466	6.48
12:50 ET	1500	6.47
12:52 ET	500	6.465
12:54 ET	1609	6.47
12:56 ET	6076	6.47
12:59 ET	74711	6.47
01:01 ET	7259	6.47
01:03 ET	59751	6.47
01:06 ET	4072	6.465
01:08 ET	200	6.465
01:10 ET	4076	6.46
01:12 ET	200	6.455
01:14 ET	21782	6.47
01:15 ET	1000	6.465
01:17 ET	5109	6.47
01:19 ET	2645	6.475
01:21 ET	1869	6.47
01:24 ET	4977	6.47
01:26 ET	2898	6.47
01:28 ET	1824	6.47
01:30 ET	11685	6.5
01:32 ET	8960	6.48
01:33 ET	100	6.47
01:35 ET	3624	6.48
01:37 ET	698	6.49
01:39 ET	3798	6.495
01:42 ET	5421	6.4901
01:44 ET	3881	6.49
01:46 ET	400	6.485
01:48 ET	401	6.4857
01:50 ET	3080	6.4899
01:51 ET	27932	6.545
01:53 ET	700	6.54
01:55 ET	2341	6.53
01:57 ET	83828	6.525
02:00 ET	2199	6.52
02:02 ET	21402	6.48
02:04 ET	6595	6.49
02:06 ET	2112	6.505
02:08 ET	2077	6.47
02:09 ET	1910	6.48
02:11 ET	4118	6.47
02:13 ET	1514	6.47
02:15 ET	2882	6.475
02:18 ET	8576	6.465
02:20 ET	1491	6.455
02:22 ET	6373	6.43
02:24 ET	2291	6.425
02:26 ET	1450	6.425
02:27 ET	4304	6.415
02:29 ET	15008	6.38
02:31 ET	18729	6.385
02:33 ET	11845	6.39
02:36 ET	1100	6.3974
02:38 ET	13075	6.415
02:40 ET	4348	6.42
02:42 ET	2929	6.395
02:44 ET	2955	6.375
02:45 ET	20994	6.32
02:47 ET	2821	6.35
02:49 ET	10691	6.33
02:51 ET	5122	6.34
02:54 ET	2976	6.32
02:56 ET	3281	6.345
02:58 ET	5837	6.365
03:00 ET	9004	6.34
03:02 ET	9520	6.35
03:03 ET	2100	6.3438
03:05 ET	3166	6.34
03:07 ET	9452	6.32
03:09 ET	3515	6.33
03:12 ET	5566	6.355
03:14 ET	3095	6.33
03:16 ET	3164	6.34
03:18 ET	23881	6.3
03:20 ET	16867	6.31
03:21 ET	11003	6.315
03:23 ET	9514	6.28
03:25 ET	24589	6.26
03:27 ET	10098	6.26
03:30 ET	10989	6.23
03:32 ET	12616	6.245
03:34 ET	3000	6.24
03:36 ET	20298	6.255
03:38 ET	5317	6.26
03:39 ET	7490	6.27
03:41 ET	10381	6.265
03:43 ET	5315	6.275
03:45 ET	6456	6.285
03:48 ET	21990	6.3
03:50 ET	6921	6.32
03:52 ET	18223	6.335
03:54 ET	30903	6.36
03:56 ET	32186	6.325
03:57 ET	44881	6.3104
03:59 ET	570071	6.3

Data delayed at least 15 minutes.

Jun 4, 2024
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
  7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
- Press Release: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
  7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 2, 2024
- BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO(R) (berotralstat) Treatment, from 4:00AM ET on Sunday Jun 02, 2024 by Dow Jones
  4:00AM ET on Sunday Jun 02, 2024 by Dow Jones
May 14, 2024
- BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology, from 7:00AM ET on Tuesday May 14, 2024 by Dow Jones
  7:00AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
- ORLADEYO(R) (berotralstat) Approved in Mexico, from 7:00AM ET on Monday May 13, 2024 by Dow Jones
  7:00AM ET on Monday May 13, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBCRX BioCryst Pharmaceuticals Inc	1.3B	-5.9x	---
United StatesMDXG MiMedx Group Inc	1.0B	19.0x	---
United StatesKNSA Kiniksa Pharmaceuticals Ltd	1.4B	222.2x	---
United StatesVCYT Veracyte Inc	1.6B	-23.6x	---
United StatesGLPG Galapagos NV	1.7B	51.9x	---
United StatesDNA Ginkgo Bioworks Holdings Inc	1.1B	-1.2x	---
As of 2024-06-12

BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older.

Contact Information

Headquarters: 4505 Emperor Blvd Ste 200DURHAM, NC, United States 27703-8457
Phone: 919-859-1302
Fax: 919-859-1314

Executives

Independent Chairman of the Board: Nancy Hutson
Chief Executive Officer, Director: Jon Stonehouse
Chief Financial Officer: Anthony Doyle
Chief Commercial Officer: Charles Gayer
Chief Research & Development Officer: Helen Thackray

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$1.3B
Revenue (TTM)	$355.4M
Shares Outstanding	206.4M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.89
EPS	$-1.07
Book Value	$-2.21
P/E Ratio	-5.9x
Price/Sales (TTM)	3.8
Price/Cash Flow (TTM)	---
Operating Margin	-33.43%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

BioCryst Pharmaceuticals Inc
NASDAQ:BCRXUnited States

Search Criteria

Charts

Recent News

Jun 4, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones

Press Release: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 2, 2024

BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO(R) (berotralstat) Treatment, from 4:00AM ET on Sunday Jun 02, 2024 by Dow Jones

May 14, 2024

BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology, from 7:00AM ET on Tuesday May 14, 2024 by Dow Jones

May 13, 2024

ORLADEYO(R) (berotralstat) Approved in Mexico, from 7:00AM ET on Monday May 13, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar